EN
FR
By Jao Smith,
Zantac was first approved for sale in the US in 1983. Within five years it was the world’s best-selling drug, with annual sales topping $1bn …
BBC – UK pharmaceutical giant GSK says it will pay as much as $2.2bn to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.
The firm announced that it had reached agreements with 10 law firms who represent around 80,000 claimants.
GSK will also pay $70m to resolve a whistleblower complaint by a laboratory that alleged the drugmaker defrauded the US government by concealing Zantac’s cancer risks.
In 2020, US regulators pulled Zantac off shelves due to fears that a key ingredient, ranitidine, could turn into a substance that may cause cancer when exposed to heat.
That move led to tens of thousands of lawsuits against the drug’s manufacturers.
The previous year, UK doctors were told to stop prescribing four types of Zantac as a “precautionary measure.”
A drug under the name of Zantac 360, which contains no ranidine, is still being currently sold.
Your Tax Free Donations Are Appreciated and Help Fund our Volunteer Website
Disclaimer: We at Prepare for Change (PFC) bring you information that is not offered by the mainstream news, and therefore may seem controversial. The opinions, views, statements, and/or information we present are not necessarily promoted, endorsed, espoused, or agreed to by Prepare for Change, its leadership Council, members, those who work with PFC, or those who read its content. However, they are hopefully provocative. Please use discernment! Use logical thinking, your own intuition and your own connection with Source, Spirit and Natural Laws to help you determine what is true and what is not. By sharing information and seeding dialogue, it is our goal to raise consciousness and awareness of higher truths to free us from enslavement of the matrix in this material realm.
